As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

The research has generated significant interest from firms in food & as consumers seek natural alternatives to GLP-1 drugs.

Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...